Previous studies have reported that ZNF667-AS1 can suppress the progression of nasopharyngeal carcinoma colorectal cancer and cervical cancer (Li et al., 2019; Chen et al., 2020; Zhuang et al., 2021). This evidence concerns the gene ZNF667 and nasopharyngeal carcinoma.